Published in J Clin Microbiol on January 01, 2004
Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol (2012) 2.78
Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother (2010) 1.73
Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection. J Immunol (2007) 1.33
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc (2011) 1.20
Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. J Clin Microbiol (2006) 1.07
Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol (2011) 1.01
Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother (2010) 0.99
Acyclovir resistance in herpes simplex virus type I encephalitis: a case report. J Neurovirol (2016) 0.97
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown. Clin Dev Immunol (2012) 0.96
Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections. Clin Dev Immunol (2012) 0.93
Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Clin Vaccine Immunol (2008) 0.92
Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob Agents Chemother (2005) 0.90
Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells. J Virol (2012) 0.88
Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Rev Med Virol (2013) 0.88
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol (2010) 0.88
Dendritic cells in viral pathogenesis: protective or defective? Int J Exp Pathol (2005) 0.86
Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis. J Viral Hepat (2010) 0.85
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci U S A (2013) 0.85
Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance. Antimicrob Agents Chemother (2015) 0.85
ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing. Antimicrob Agents Chemother (2004) 0.84
Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol (2012) 0.83
Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am (2010) 0.82
UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance. J Biol Chem (2014) 0.82
Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles. Evid Based Complement Alternat Med (2011) 0.82
Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures. Br J Pharmacol (2008) 0.81
Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease. Med Microbiol Immunol (2014) 0.80
Viral infection in renal transplant recipients. ScientificWorldJournal (2012) 0.79
Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA. Proc Natl Acad Sci U S A (2012) 0.78
Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients. PLoS One (2016) 0.77
Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance. J Pediatric Infect Dis Soc (2012) 0.77
Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir. Acta Naturae (2016) 0.75
Optimal management of genital herpes: current perspectives. Infect Drug Resist (2016) 0.75
Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility. Sci Rep (2016) 0.75
Herpes Genitalis: Diagnosis, Treatment and Prevention. Geburtshilfe Frauenheilkd (2016) 0.75
Acute Liver Failure from Herpes Simplex Virus in an Immunocompetent Patient Due to Direct Inoculation of the Peritoneum. ACG Case Rep J (2017) 0.75
Evaluation of cytotoxic potential of newly synthesized antiviral aminopyrazoloquinoline derivatives. Int J Biomed Sci (2007) 0.75
Oxoquinoline derivatives: identification and structure-activity relationship (SAR) analysis of new anti-HSV-1 agents. Curr Microbiol (2011) 0.75
Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir. Dokl Biochem Biophys (2015) 0.75
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53
A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS. Proc Soc Exp Biol Med (1964) 2.47
The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol (1989) 2.40
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci U S A (1988) 2.27
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89
Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83
Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J Gen Virol (1986) 1.69
A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res (1983) 1.69
Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med (1993) 1.57
Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis (1982) 1.56
Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis (1994) 1.49
Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol (1992) 1.44
Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob Agents Chemother (1987) 1.27
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. N Engl J Med (1989) 1.22
A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J Biol Stand (1986) 1.21
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis (2000) 1.19
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. J Infect Dis (1998) 1.10
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood (2002) 1.02
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob Agents Chemother (1997) 1.01
Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis (2000) 0.96
Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey. J Antimicrob Chemother (2000) 0.95
In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme. J Virol (1989) 0.94
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (1996) 0.93
Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Bone Marrow Transplant (1998) 0.91
Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob Agents Chemother (2002) 0.86
Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Dermatology (1995) 0.85
Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Bone Marrow Transplant (2000) 0.84
Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clin Infect Dis (1995) 0.84
Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis. Antimicrob Agents Chemother (2002) 0.81
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child. Pediatr Infect Dis J (2001) 0.81
A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir. J Virol Methods (2002) 0.78
Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues. Chemotherapy (2000) 0.78
16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol (2000) 16.27
Q fever. Clin Microbiol Rev (1999) 11.32
Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect (2012) 7.97
Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis (2001) 5.61
Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science (2001) 5.32
Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol (1997) 5.19
Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae. Int J Syst Bacteriol (1997) 5.09
Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med (1995) 4.99
Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev (2001) 4.92
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65
Differentiation of spotted fever group rickettsiae by sequencing and analysis of restriction fragment length polymorphism of PCR-amplified DNA of the gene encoding the protein rOmpA. J Clin Microbiol (1996) 4.64
rpoB sequence analysis as a novel basis for bacterial identification. Mol Microbiol (1997) 4.51
Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med (1987) 4.38
The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest (1997) 4.29
Diagnosis of Q fever. J Clin Microbiol (1998) 4.16
A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res Microbiol (1992) 3.93
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis (1998) 3.81
Phylogenetic analysis of members of the genus Rickettsia using the gene encoding the outer-membrane protein rOmpB (ompB). Int J Syst Evol Microbiol (2000) 3.74
Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science (1997) 3.67
Isolation of a 7S particle from Xenopus laevis oocytes: a 5S RNA-protein complex. Proc Natl Acad Sci U S A (1979) 3.49
Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods (2005) 3.48
Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med (1999) 3.43
Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol (1999) 3.35
Inter- and intraspecies identification of Bartonella (Rochalimaea) species. J Clin Microbiol (1995) 3.27
Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol (1994) 3.26
Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med (1992) 3.13
Causes of acute, undifferentiated, febrile illness in rural Thailand: results of a prospective observational study. Ann Trop Med Parasitol (2006) 3.09
Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother (2004) 3.09
Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med (1991) 3.06
Phylogenetic analysis of the genus Rickettsia by 16S rDNA sequencing. Res Microbiol (1995) 3.02
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Sex in Escherichia coli does not disrupt the clonal structure of the population: evidence from random amplified polymorphic DNA and restriction-fragment-length polymorphism. J Mol Evol (1995) 2.96
Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rOmpA. Int J Syst Bacteriol (1998) 2.95
Detection of 400-year-old Yersinia pestis DNA in human dental pulp: an approach to the diagnosis of ancient septicemia. Proc Natl Acad Sci U S A (1998) 2.92
A new tick-transmitted disease due to Rickettsia slovaca. Lancet (1997) 2.83
A simple method for the isolation of chromosomal DNA from gram positive or acid-fast bacteria. Nucleic Acids Res (1991) 2.82
A simple method for amplification of DNA from paraffin-embedded tissues. Nucleic Acids Res (1992) 2.76
Comparison of partial citrate synthase gene (gltA) sequences for phylogenetic analysis of Bartonella species. Int J Syst Bacteriol (1996) 2.69
Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG (2013) 2.67
Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii. J Clin Microbiol (1996) 2.65
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology (2001) 2.65
The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiol Infect (2010) 2.64
Outbreak of scrub typhus in southern India during the cooler months. Ann N Y Acad Sci (2003) 2.63
HIV infection en route to endogenization: two cases. Clin Microbiol Infect (2014) 2.63
Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol (2004) 2.61
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med (1998) 2.55
Detection and identification of spotted fever group Rickettsiae and Ehrlichiae in African ticks. Emerg Infect Dis (2001) 2.54
The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur J Clin Microbiol Infect Dis (2013) 2.54
New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet (1996) 2.51
Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg (1989) 2.48
Phylogenesis of relapsing fever Borrelia spp. Int J Syst Bacteriol (1996) 2.47
Current knowledge of Bartonella species. Eur J Clin Microbiol Infect Dis (1997) 2.44
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg (1986) 2.42
Use of rpoB gene analysis for detection and identification of Bartonella species. J Clin Microbiol (2001) 2.39
Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond) (2011) 2.39
Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int J Syst Evol Microbiol (2001) 2.37
Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) (2001) 2.37
Molecular diagnosis of infective endocarditis--a new Duke's criterion. Scand J Infect Dis (2001) 2.36
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis (2000) 2.34
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology (2000) 2.28
Serological differentiation of murine typhus and epidemic typhus using cross-adsorption and Western blotting. Clin Diagn Lab Immunol (2000) 2.26
An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis (1994) 2.26
Human granulocytic ehrlichiosis in Europe. Lancet (1995) 2.25
Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human. J Clin Microbiol (2000) 2.23
Genotypic and antigenic identification of two new strains of spotted fever group rickettsiae isolated from China. J Clin Microbiol (1993) 2.23
Rickettsia aeschlimannii sp. nov., a new spotted fever group rickettsia associated with Hyalomma marginatum ticks. Int J Syst Bacteriol (1997) 2.19
A new spotted-fever-group rickettsiosis. Lancet (1996) 2.19
Risks factors and prevention of Q fever endocarditis. Clin Infect Dis (2001) 2.17
Bartonella (Rochalimaea) quintana infections. Clin Microbiol Rev (1996) 2.17
Rickettsia africae sp. nov., the etiological agent of African tick bite fever. Int J Syst Bacteriol (1996) 2.13
Differentiation among spotted fever group rickettsiae species by analysis of restriction fragment length polymorphism of PCR-amplified DNA. J Clin Microbiol (1994) 2.12
Massilia timonae gen. nov., sp. nov., isolated from blood of an immunocompromised patient with cerebellar lesions. J Clin Microbiol (1998) 2.11
Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med (1996) 2.10
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol (1997) 2.08
Selfish DNA in protein-coding genes of Rickettsia. Science (2000) 2.07
Phylogeny of Rickettsia spp. inferred by comparing sequences of 'gene D', which encodes an intracytoplasmic protein. Int J Syst Evol Microbiol (2001) 2.07
Q fever: still a mysterious disease. QJM (2002) 2.06
Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever. J Clin Microbiol (1992) 2.04
Cross-reaction of immune sera from patients with rickettsial diseases. J Med Microbiol (1989) 2.04
[Pathogen role of coronavirus in pediatric intensive care: retrospective analysis of 19 positive samples with indirect immunofluorescence]. Arch Pediatr (1994) 2.02
Coxiella burnetii blood cultures from acute and chronic Q-fever patients. J Clin Microbiol (1995) 2.01
Characterization of lexB mutations in Escherichia coli K-12. J Bacteriol (1977) 1.99
Positive predictive value of Rochalimaea henselae antibodies in the diagnosis of cat-scratch disease. Clin Infect Dis (1994) 1.98
Evidence of Rickettsia helvetica infection in humans, eastern France. Emerg Infect Dis (2000) 1.97
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J Clin Microbiol (1993) 1.94
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat. Lancet (1994) 1.94
Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J Clin Microbiol (1993) 1.94
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
Is molecular biology the best alternative for diagnosis of malaria to microscopy? A comparison between microscopy, antigen detection and molecular tests in rural Kenya and urban Tanzania. Trop Med Int Health (2007) 1.92
Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury. Clin Infect Dis (2001) 1.90
In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother (1986) 1.89
Prevalence of antibodies to Coxiella burnetti, Rickettsia conorii, and Rickettsia typhi in seven African countries. Clin Infect Dis (1995) 1.88
Chlamydia-like obligate parasite of free-living amoebae. Lancet (1997) 1.88